Interestingly, it was reported that a subpopulation of CD133+ CRCSCs isolated from primary tumours had a level of glycolysis significantly higher than that of CD133− cells31, consistent with the metabolic traits of CRCSCs in our research. The gene discussed is PROM1; the disease is neoplasm.